Related Experiment Video
Updated: Mar 11, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
L'RRK de Triomphe: a solution for LRRK2 GTPase activity?
Jonathon Nixon-Abell1,2, Daniel C Berwick3, Kirsten Harvey1
1Department of Pharmacology, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, U.K.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is a central protein in the pathogenesis of Parkinson's disease (PD), yet its normal function has proved stubbornly hard to elucidate. Even though it remains unclear how pathogenic mutations affect LRRK2 to cause PD, recent findings provide increasing cause for optimism. We summarise here the developing consensus over the effect of pathogenic mutations in the Ras of complex proteins and C-terminal of Roc domains on LRRK2 GTPase activity. This body of work has been greatly reinforced by our own study of the protective R1398H variant contained within the LRRK2 GTPase domain. Collectively, data point towards the pathogenicity of GTP-bound LRRK2 and strengthen a working model for LRRK2 GTPase function as a GTPase activated by dimerisation. Together with the identification of the protective R1398H variant as a valuable control for pathogenic mutations, we have no doubt that these triumphs for the LRRK2 field will accelerate research towards resolving LRRK2 function and towards new treatments for PD.
Insights
Leucine-rich repeat kinase 2 (LRRK2) is key in Parkinson's disease (PD) pathogenesis. Pathogenic mutations may cause PD by increasing LRRK2 GTPase activity, with a protective variant aiding research.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease (PD) pathogenesis.
- The precise function of LRRK2 and the impact of mutations remain unclear.
- LRRK2 mutations are a significant genetic factor in PD.
Purpose of the Study:
- To elucidate the function of LRRK2, particularly its GTPase activity.
- To understand how pathogenic mutations affect LRRK2 function in PD.
- To investigate the role of the R1398H variant in LRRK2 function.
Main Methods:
- Analysis of LRRK2 GTPase activity in relation to pathogenic mutations.
- Investigating the effect of mutations in the Ras and Roc domains.
- Characterization of the protective R1398H variant.
Main Results:
- A consensus is emerging regarding the effect of pathogenic mutations on LRRK2 GTPase activity.
- GTP-bound LRRK2 is identified as pathogenic.
- LRRK2 functions as a GTPase activated by dimerisation.
- The R1398H variant serves as a control for pathogenic mutations.
Conclusions:
- LRRK2 GTPase activity is central to its role in PD.
- Understanding LRRK2 function is crucial for developing PD treatments.
- The R1398H variant provides a valuable tool for LRRK2 research.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
GTPases and their Regulation
Large G-proteins,...
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
GPCRs Regulate Adenylyl Cylase Activity
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

